The outcome of sonodynamic immunotherapy is significantly limited by tumor hypoxia. To overcome this obstacle, one common solution is to catalyze the conversion of endogenous H
2
O
2
into O
2
. However, the effectiveness of this strategy is limited by the insufficient concentration of H
2
O
2
in the tumor microenvironment (TME). Herein, we developed a H
2
O
2
economizer for on-demand O
2
supply and sonosensitizer-mediated reactive oxygen species production during ultrasound activation, thereby alleviating hypoxia-associated limitations and augmenting the efficacy of sonodynamic immunotherapy.
Methods:
The H
2
O
2
economizer is constructed by electrostatic adsorption and π-π interactions between the Fe-doped polydiaminopyridine (Fe-PDAP) nanozyme and chlorin e6. By employing a biomimetic engineering strategy with cancer cell membranes, we addressed the premature leakage issue and increased tumor-site accumulation of nanoparticles (membrane-coated Fe-PDAP/Ce6, MFC).
Results:
The prepared MFC could significantly attenuate the catalytic activity of Fe-PDAP by reducing their contact with H
2
O
2
. Ultrasound irradiation promoted MFC dissociation and the exposure of Fe-PDAP for a more robust O
2
supply. Moreover, the combination of MFC-enhanced sonodynamic therapy with anti-programmed cell death protein-1 antibody (aPD-1) immune checkpoint blockade induced a strong antitumor response against both primary tumors and distant tumors.
Conclusion:
This as-prepared H
2
O
2
economizer significantly alleviates tumor hypoxia via reducing H
2
O
2
expenditure and that on-demand oxygen-elevated sonodynamic immunotherapy can effectively combat tumors.
This study provides an efficient theranostic strategy for concurrent targeted ultrasound molecular imaging and effective synergistic antitumor therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.